@article{TCR10640,
author = {Narendra Nath Basu and D. Gareth Evans},
title = {Risk of contralateral breast cancer amongst BRCA1/2 mutation carriers},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 6},
year = {2016},
keywords = {},
abstract = {Women harbouring a deleterious mutation in the high penetrance BRCA1/2 genes have a lifetime risk of up to 85% of developing breast cancer (1). Once diagnosed, they have a significant risk of developing a contralateral breast cancer—approximately 2–3% per year. This risk persists for up to 30 years following an initial breast cancer diagnosis (2).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/10640}
}